News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • White House calls Correspondents' Dinner shooting a third major assassination attempt on President, prompting urgent security reviews and DHS funding demands.
  • Trump and First Lady demanded ABC/Disney fire Jimmy Kimmel over a late-night skit, escalating political pressure on broadcasters.
  • DeSantis unveiled a Florida congressional map to flip four Democratic seats and called a special session, setting up near-term legal fights.
  • Domino's U.S. same-store sales missed estimates, cut its domestic sales forecast, and warned of wider headwinds for quick-service restaurants.
  • JPMorgan and Kuwaiti lenders joined HSBC to underwrite a $6 billion loan for buyers of a KPC pipeline stake, with bids delayed by regional conflict worries.
  • Over 580 Alphabet AI researchers urged CEO Pichai to block classified U.S. defense workloads, intensifying governance pressure on tech firms.
  • RBC Capital Markets hired three senior credit traders to bolster single-name, electronic US credit, and high-yield trading leadership.

Latest Articles

LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia

LB Pharmaceuticals Initiates Pivotal Phase 3 Trial (NOVA-2) for LB-102 in Patients with Schizophrenia

LB Pharmaceuticals has commenced its pivotal Phase 3 NOVA-2 trial to evaluate LB-102, a novel oral benzamide antipsychotic candidate, for the treatment of schizophrenia in approximately 460 U.S. patients. LB-102 showed promising Phase 2 results with significant symptom improvement and a favorable safety profile. Topline data from NOVA-2 are expecte…

zSpace and Atlanta Public Schools Demonstrate a Decade of Impact Using AR/VR to Transform STEM and Career Education

zSpace and Atlanta Public Schools Demonstrate a Decade of Impact Using AR/VR to Transform STEM and Career Education

zSpace, Inc. highlights a successful partnership with Atlanta Public Schools, demonstrating the transformative power of its AR/VR learning platform in enhancing STEM education and career readiness across multiple school levels over nearly ten years. The immersive technology facilitates hands-on learning experiences that prepare students for workfor…

BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine

BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine

BullFrog AI Holdings has introduced bfARENAS™, a new AI-powered decision engine designed to support pharmaceutical and biotech companies in optimizing portfolio strategies and clinical trial designs. The tool evaluates options under multiple strategic scenarios, aiming to reduce risk and improve R&D decision-making efficiency amid clinical trial un…

Kaltura Achieves ISO/IEC 42001 Compliance Certification, The Global Standard for Secure and Trustworthy AI

Kaltura Achieves ISO/IEC 42001 Compliance Certification, The Global Standard for Secure and Trustworthy AI

Kaltura has obtained ISO/IEC 42001 certification, the global standard for Artificial Intelligence Management Systems, recognizing its ability to manage AI-related risks including security and operational misuse. This certification enhances trust in Kaltura’s AI offerings, especially for customers in regulated sectors like financial services, health…

Buy-the-Dip Setup: Microsoft’s Balance Sheet Makes a Convincing Long

Buy-the-Dip Setup: Microsoft’s Balance Sheet Makes a Convincing Long

Microsoft (MSFT) is trading near its 52-week low after a heavy sell-off tied to AI capex and margin worries. With a $2.77T market cap, strong free cash flow ($77.4B trailing), low leverage (debt/equity ~0.10) and an oversold technical picture (RSI ~28), the pullback looks like a high-probability long setup. This trade pairs a tactical entry at $376…

PDD Shares Swing After Fourth-Quarter Revenue Nearly Meets Estimates

PDD Shares Swing After Fourth-Quarter Revenue Nearly Meets Estimates

PDD Holdings reported fourth-quarter revenue of 123.91 billion yuan, narrowly missing the average analyst estimate of 124.4 billion yuan compiled by LSEG. Revenue rose 39% from the prior year, while net income fell 11% to 24.54 billion yuan. Shares experienced sharp intraday moves following the release, after a sizable year-to-date decline prior to…

Beretta Proposes Tender Offer for Stake in Sturm, Ruger; Shares Rise

Beretta Proposes Tender Offer for Stake in Sturm, Ruger; Shares Rise

Sturm, Ruger & Company shares rose after Beretta Holding S.A. announced a tender offer to buy up to 20.05% of the gunmaker at $44.80 a share. Beretta says it aims to acquire beneficial ownership of up to 30% of outstanding shares, has asked Ruger to waive a poison pill adopted on October 14, 2025, and said the tender will proceed only if the exempt…

Bernstein Lowers Nifty Year-End Target, Warns of Potential 'GFC Moment' if Middle East Conflict Persists

Bernstein Lowers Nifty Year-End Target, Warns of Potential 'GFC Moment' if Middle East Conflict Persists

Bernstein has reduced its year-end Nifty target to 26,000 from 28,100, citing risks from a prolonged Middle East conflict that could combine rising crude prices, a softer rupee and higher inflation to produce macro conditions reminiscent of India’s post-2008 global financial crisis. The firm outlines four scenarios for the index and highlights vuln…

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

Artelo Biosciences Expansion into $16.3B Glaucoma Market, Via Fully Funded Study, Highlights Multi-Platform Pipeline Strength

Artelo Biosciences announced a fully funded clinical study expanding its lead compound ART27.13 into the $16.3 billion glaucoma market, complementing its existing pipeline targeting oncology support, neuropathic pain, and CNS disorders. The company highlights positive interim Phase 2 data, European patent protection through 2041, supportive regulat…

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP TMS S.A. announced record fourth quarter and full-year 2025 revenue growth in its High-Intensity Focused Ultrasound (HIFU) business, with a 39% year-over-year increase driven by stronger global demand for the Focal One system. The company reported increased system sales, notably 14 cash sales in Q4, and 28% growth in U.S. Focal One procedures.…

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Anavex Life Sciences Provides Update on Regulatory Review in the EU for Blarcamesine to Treat Early Alzheimer’s Disease

Anavex Life Sciences has withdrawn its application for European marketing authorization of blarcamesine as an add-on treatment for early Alzheimer's disease after the EMA's Committee for Medicinal Products for Human Use indicated it would not issue a positive opinion at this time. The company plans to gather additional data and conduct further anal…

Creative Realities Appoints Jackie Walker as CXO to Lead Experience Strategy and Next Generation SaaS Platform Vision

Creative Realities Appoints Jackie Walker as CXO to Lead Experience Strategy and Next Generation SaaS Platform Vision

Creative Realities, Inc. (NASDAQ: CREX), a leading provider of digital signage and AdTech solutions, has appointed Jackie Walker as Chief Experience Officer. With over 15 years’ experience in digital transformation and expertise in retail media networks and QSR digital merchandising, Walker will lead the company’s transition into a software-first p…

Rekor Systems Appoints Marc Segal as Director of Rekor Command® to Drive Expansion in Key Growth Markets

Rekor Systems Appoints Marc Segal as Director of Rekor Command® to Drive Expansion in Key Growth Markets

Rekor Systems, a NASDAQ-listed leader in roadway intelligence systems, announced the appointment of Marc Segal as Technical Account Management Director for its Rekor Command® real-time traffic operations platform. Based in Austin, Texas, Segal's role aims to accelerate adoption and expand the platform’s presence, leveraging his expertise and existi…

Nanobiotix Shares Jump After Report That J&J Is Evaluating Takeover

Nanobiotix Shares Jump After Report That J&J Is Evaluating Takeover

Nanobiotix shares climbed sharply after a French publication reported that Johnson & Johnson is examining a potential takeover. The move followed the disclosure that Nanobiotix is partnered with J&J on a cancer drug, but company and Johnson & Johnson representatives did not immediately comment. Analysts say a buyout is unlikely at this stage becaus…

Cipher Digital Secures 15-Year Hyperscale Lease, Raises $200M Revolver

Cipher Digital Secures 15-Year Hyperscale Lease, Raises $200M Revolver

Cipher Digital Inc. reported a new 15-year lease for a high-performance computing (HPC) data center campus with an investment-grade hyperscale tenant and finalized a $200 million revolving credit facility. The lease represents the company's third campus agreement and covers development and delivery of an HPC data center at an existing site. The cre…

Codere Weighs Sale That Could Top 2 Billion Euros, Advisers Appointed

Codere Weighs Sale That Could Top 2 Billion Euros, Advisers Appointed

Spanish gambling operator Codere has engaged Jefferies and Macquarie Capital to advise on a potential sale that could value the company at over 2 billion euros. The sale process is at an early stage, with indicative bids expected by mid-May, binding offers around early July, and a closing aimed for before the August summer break. The proposed trans…